After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Ngm Biopharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Ngm Biopharmaceuticals Inc is $131.03M. A total of 1.18 million shares were traded on the day, compared to an average of 1.32M shares.
In the most recent transaction, COLUMN GROUP L P bought 5,840 shares of NGM for 0.62 per share on Nov 16 ’23. After the transaction, the Director now owns 949,862 company shares. In a previous transaction on Nov 16 ’23, COLUMN GROUP L P bought 5,840 shares at 0.62 per share. NGM shares that Director owns now total 949,862.
Among the insiders who bought shares, COLUMN GROUP L P acquired of 5,840 shares on Nov 16 ’23 at a per-share price of $0.62. This resulted in the Director holding 949,862 shares of NGM after the transaction. In another insider transaction, GOEDDEL DAVID V bought 5,840 shares at $0.62 per share on Nov 16 ’23. Company shares held by the Director now total 949,862.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NGM has a high of $4.69 and a low of $0.60.
As of this writing, NGM has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.35 in the last quarter, which was 16.70% higher than expectations of -$0.42.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NGM’s latest balance sheet shows that the firm has $366.25M in Cash & Short Term Investments as of fiscal 2021. There were $10.46M in debt and $61.35M in liabilities at the time. Its Book Value Per Share was $1.79, while its Total Shareholder’s Equity was $335.65M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NGM is Buy with a score of 3.00.
